https://openreview.net/forum?id=g3VCIM94ke&referrer=%5Bthe%20profile%20of%20Bruno%20Correia%5D(%2Fprofile%3Fid%3D~Bruno_Correia1)
Multi-domain Distribution Learning for De Novo Drug Design | OpenReview
We introduce DrugFlow, a generative model for structure-based drug design that integrates continuous flow matching with discrete Markov bridges, demonstrating...
de novo drug designmulti domainlearning fordistributionopenreview
https://openreview.net/forum?id=W1tcNQNG1S
An evaluation framework for the objective functions of de novo drug design benchmarks | OpenReview
Most common benchmark objectives are irrelevant and don't resemble realistic functions in drug design: we should change this!
de novo drug design
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-for-de-novo-drug-design-market-report
AI For De Novo Drug Design Market Share Report 2026
The Artificial Intelligence (AI) For De Novo Drug Design market size is expected to reach $8.07 billion in 2030 at a CAGR of 33.7%, driven by complex disease...
de novo drug designai formarket sharereport2026